Placebo tablet manufactured by Laboratoria Wolfs
Sponsors
UZ Leuven
Conditions
Rumination Syndromegastro-esophageal reflux disease
Phase 4
A placebo-controlled trial with prucalopride for the treatment of typical reflux symptoms in patients with gastro-esophageal reflux disease with incomplete proton pump inhibitor response.
RecruitingCTIS2024-516317-21-00
Start: 2018-04-09Target: 60Updated: 2024-10-10
A placebo-controlled trial with citalopram for the treatment of typical reflux symptoms in patients with reflux hypersensitivity or functional heartburn with incomplete proton pump inhibitor response.
RecruitingCTIS2024-517019-57-00
Start: 2018-04-10Target: 100Updated: 2024-10-23
A Randomized, Double Blind, Placebo Controlled, Crossover Trial of Clebopride vs Placebo in the Treatment of Clinically Suspected Rumination Syndrome.
RecruitingCTIS2024-516573-71-00
Start: 2019-10-03Target: 20Updated: 2024-10-29